据港交所文件,汇丰控股(00005.HK)于5月20日耗资1.176亿港元回购了130万股股份。
news flash· 2025-05-21 08:48
Group 1 - HSBC Holdings (00005.HK) repurchased 1.3 million shares at a cost of HKD 117.6 million on May 20 [1]
港股收评:恒指涨0.62%,医药、黄金股强势拉升,美图公司飙涨近19%
Ge Long Hui A P P· 2025-05-21 08:45
Market Overview - The Hong Kong stock market saw all three major indices rise, with the Hang Seng Index up 0.62% to 23827.78, the Hang Seng China Enterprises Index up 0.84% to 8660.94, and the Hang Seng Tech Index up 0.51% to 5342.41, marking a two-day consecutive increase [1][2]. Sector Performance - Large tech stocks mostly rose, with Alibaba increasing over 1%, while Kuaishou, NetEase, JD.com, Tencent, and Meituan saw gains within 1% [4]. - Gold stocks performed strongly, with Chifeng Jilong Gold rising nearly 14% as gold prices surpassed $3300 per ounce [5][6]. - Automotive stocks remained active, with BYD and Li Auto both rising 4%, and BYD reaching a historical high [8]. - Pharmaceutical stocks surged due to a resurgence of COVID-19 cases, with companies like Kailaiying and Sanofi seeing significant increases [10]. - Sportswear stocks also saw gains, with Anta Sports up 5.77% and Li Ning up 0.92% [7]. Notable Individual Stocks - Meitu's stock rose 18.98% to HKD 7.02 after announcing a $250 million convertible bond agreement with Alibaba [14]. - CATL's stock increased by 10.19% to HKD 337.4, with a market capitalization exceeding HKD 1.5 trillion, as the company focuses on zero-carbon technology [17]. Investment Trends - Southbound funds recorded a net inflow of HKD 1.427 billion, indicating strong interest in Hong Kong stocks [20]. - Analysts remain optimistic about the Hong Kong market's relative performance, particularly in technology and consumer sectors, as the Chinese growth outlook improves [20].
据港交所文件,汇丰控股(00005.HK)于5月20日耗资870万英镑在其他证券交易所回购了总计98.151万股股份。
news flash· 2025-05-21 08:43
Group 1 - HSBC Holdings repurchased a total of 981,510 shares at a cost of £8.7 million on May 20 [1]
迅捷环球控股(00540.HK)5月21日收盘上涨7.36%,成交2.32万港元
Jin Rong Jie· 2025-05-21 08:39
最近一个月来,迅捷环球控股累计跌幅0.61%,今年来累计涨幅14.79%,跑输恒生指数18.05%的涨幅。 财务数据显示,截至2024年12月31日,迅捷环球控股实现营业总收入6.12亿元,同比增长42.87%;归母 净利润1565.1万元,同比增长441.43%;毛利率12.33%,资产负债率69.6%。 机构评级方面,目前暂无机构对该股做出投资评级建议。 行业估值方面,纺织及服饰行业市盈率(TTM)平均值为-6.59倍,行业中值-0.17倍。迅捷环球控股市 盈率5.79倍,行业排名第17位;其他FAST RETAIL-DRS(06288.HK)为0.36倍、浙江永安 (08211.HK)为1.34倍、都市丽人(02298.HK)为3.78倍、其利工业集团(01731.HK)为3.92倍、杉杉 品牌(01749.HK)为4.1倍。 资料显示,迅捷环球控股有限公司为领先的供应链服务,主要为全球知名品牌提供产品设计及开发、确 认时装潮流及取样、采购原材料、生产订单及采购管理、品质监控、包装、存货管理及物流管理的全面 服务,以及於中国经营服装零售业务及物业发展及投资。 5月21日,截至港股收盘,恒生指数上涨0.6 ...
创新鲜果冰奶、green店火成现象级 奈雪(02150)战略升级后销量暴涨290%!
智通财经网· 2025-05-21 08:35
Group 1 - The core viewpoint of the articles highlights the impressive sales performance of Nayuki after its strategic upgrade, with significant sales increases driven by innovative products and new store openings [1][4] - The new product "Dai Dai Hua Pan Tao Ice Milk" has quickly gained popularity, ranking second on the delivery platform's trending list, with some stores experiencing a 290% month-on-month sales increase [1] - Nayuki's second Green store opened in Shenzhen, attracting massive crowds and achieving over a thousand orders on its first day, demonstrating strong consumer interest in health-oriented products [1][4] Group 2 - The "Flash Purchase" collaboration with delivery platforms led to a more than 200% year-on-year increase in order volume within 24 hours, positioning Nayuki ahead of other tea brands [1] - The product lineup, including "Daily 500 Vegetable and Fruit Bottle" and "Seasonal Green" series, reflects a growing consumer preference for health-conscious options [3] - Nayuki is accelerating the nationwide rollout of Green stores, with 31 locations opened in major cities, indicating a robust demand for healthy and light food and beverage options [4]
ST浩丰(300419)5月21日主力资金净流入1730.53万元
Sou Hu Cai Jing· 2025-05-21 08:34
金融界消息 截至2025年5月21日收盘,ST浩丰(300419)报收于5.39元,上涨3.26%,换手率3.74%,成 交量13.75万手,成交金额7397.04万元。 通过天眼查大数据分析,北京浩丰创源科技股份有限公司共对外投资了15家企业,参与招投标项目422 次,知识产权方面有商标信息15条,专利信息1条,此外企业还拥有行政许可5个。 来源:金融界 ST浩丰最新一期业绩显示,截至2025一季报,公司营业总收入4543.51万元、同比减少20.58%,归属净 利润503.24万元,同比减少40.85%,扣非净利润518.45万元,同比减少32.84%,流动比率1.719、速动比 率1.498、资产负债率36.64%。 天眼查商业履历信息显示,北京浩丰创源科技股份有限公司,成立于2005年,位于北京市,是一家以从 事科技推广和应用服务业为主的企业。企业注册资本36775.377万人民币,实缴资本36775.377万人民 币。公司法定代表人为王剑。 资金流向方面,今日主力资金净流入1730.53万元,占比成交额23.39%。其中,超大单净流入548.45万 元、占成交额7.41%,大单净流入1182.08万 ...
帝国金融集团(08029.HK)5月21日收盘上涨18.33%,成交2.37万港元
Jin Rong Jie· 2025-05-21 08:33
机构评级方面,目前暂无机构对该股做出投资评级建议。 5月21日,截至港股收盘,恒生指数上涨0.62%,报23827.78点。帝国金融集团(08029.HK)收报0.71港 元/股,上涨18.33%,成交量3.5万股,成交额2.37万港元,振幅21.67%。 最近一个月来,帝国金融集团累计涨幅20%,今年来累计涨幅60%,跑赢恒生指数18.05%的涨幅。 财务数据显示,截至2024年9月30日,帝国金融集团实现营业总收入1399.94万元,同比增长34.9%;归 母净利润-1941.73万元,同比减少495.96%;毛利率20.28%,资产负债率153.95%。 行业估值方面,其他金融行业市盈率(TTM)平均值为21.19倍,行业中值-0.09倍。帝国金融集团市盈 率-4.44倍,行业排名第123位;其他东方汇财证券(08001.HK)为1.93倍、招商局中国基金 (00133.HK)为2.2倍、国银金租(01606.HK)为3.2倍、香港信贷(01273.HK)为3.27倍、中关村科技 租赁(01601.HK)为3.64倍。 资料显示,帝国金融集团有限公司於香港联合交易所创业版上市,股票编号为:8029。本集 ...
惠陶集团(08238.HK)5月21日收盘上涨16.8%,成交26.32万港元
Jin Rong Jie· 2025-05-21 08:33
行业估值方面,媒体及娱乐行业市盈率(TTM)平均值为-5.14倍,行业中值-1.21倍。惠陶集团市盈 率-0.55倍,行业排名第102位;其他华视集团控股(01111.HK)为1.73倍、耀星科技集团(08446.HK) 为2.77倍、瓦普思瑞元宇宙(08093.HK)为3.29倍、国恩控股(08121.HK)为3.38倍、中国创意控股 (08368.HK)为6.48倍。 资料显示,惠陶集团(控股)有限公司于2015年2月16号成功在香港联交所创业板上市,为本集团奠下里程 碑。自惠陶集圑的首份销售杂志《名车站》及首份免费杂志《名车站睇楼站生活站赠阅版》于2009年4 月出版以来,惠陶集圑至今已拥有六份杂志,并有多个销售点覆盖香港不同地点及1,000多个派发点,包括油 站、足浴店、发廊、咖啡店等。此外,本集团已建立一个超过100名客户的广泛客户群,行业广及汽车销售 代理、美容品牌拥有人、地产代理、珠宝、专业公司、宠物店等。在短短数年,惠陶集圑已发展至今日 的规模,这全是本集圑管理层及全体员工努力不懈的成果。 在2014年,受惠于新业务伙伴的新增赠阅点,本集圑的经营业绩稳步上扬。同时,2013年中出版的免费杂志 ...
阿里大文娱变局:集团更名“虎鲸文娱”,阿里影业走向大麦娱乐丨消费现场
2 1 Shi Ji Jing Ji Bao Dao· 2025-05-21 08:33
21世纪经济报道记者 贺泓源 北京报道 阿里大文娱变了。 5月21日,阿里大文娱集团宣布即日起更名为虎鲸文娱集团,旗下阿里影业拟更名为大麦娱乐。 在发布会上,优酷首席运营官、阿里鱼总裁吴倩甚至将此种变化与淘宝商城更名为天猫的转折作为对 比。"今天天猫已经家喻户晓。而虎鲸文娱集团崭新的名称就是需要我们以归零的心态,以创业者的姿 态,从此开启一段崭新的征程。虽然名字变了,但持续为用户提供精品内容、不断优化服务体验,借助 AI为行业带来更良性发展的初心与业务战略始终没变。"她称。 在最新财年,大麦营收20.57亿元,同比增长236%;分部业绩(扣除成本及销售费用)12.3 亿元,同比 增长339%。营收及业绩大幅提升主因是,演出市场景气带动大麦票务GMV及现场演出内容业务增长。 据中国演出行业协会,2024年全国营业性演出票房同比增长15.4%,大型演唱会同比增长78.1%。 作为对比,电影市场则成为阿里影业的营收拖累项。 最新财年,阿里影业将电影相关分部合并为"电影科技与投资制作宣发平台"分部,营收27.12 亿元,同 比下滑10%;分部业绩 0.73 亿,同比下滑91%。主要原因是,部分电影项目不及预期,以及2 ...
紫元元(08223.HK)5月21日收盘上涨9.3%,成交235.81万港元
Sou Hu Cai Jing· 2025-05-21 08:28
Company Overview - Ziyuan Yuan Holdings Limited (stock code: 08223.HK) is listed on the Hong Kong Stock Exchange and is headquartered in Shenzhen, China. The company has established offices in various cities including Beijing, Hangzhou, Wuhan, Henan, Chengdu, Guangzhou, and Hong Kong [3]. Financial Performance - As of December 31, 2024, Ziyuan Yuan reported total revenue of 552 million yuan, representing a year-on-year growth of 10.91%. However, the net profit attributable to shareholders was a loss of 52.97 million yuan, a significant decrease of 463.73% compared to the previous year. The gross profit margin stood at 15.67%, and the debt-to-asset ratio was 49.94% [2]. Stock Performance - The stock price of Ziyuan Yuan closed at 1.41 HKD per share on May 21, with an increase of 9.3%. The trading volume was 1.764 million shares, with a total turnover of 2.3581 million HKD and a price fluctuation of 15.5%. However, over the past month, the stock has experienced a cumulative decline of 41.36%, and since the beginning of the year, it has dropped by 18.87%, underperforming the Hang Seng Index, which has risen by 18.05% [1][2]. Industry Valuation - Currently, there are no institutional investment ratings for Ziyuan Yuan. The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -21.51 times, with a median of 0.31 times. Ziyuan Yuan's P/E ratio is -9.7 times, ranking 75th in the industry. Comparatively, other companies in the sector have P/E ratios such as Giant Medical Holdings (0.23), Jingjiu Health (0.38), Yongsheng Medical (3.87), Global Medical (4.63), and Ruici Medical (5.6) [2][3]. Business Model - Ziyuan Yuan provides comprehensive services to medical institutions, patients, and healthcare enterprises. The company has established brand influence in consumer healthcare sectors such as dental care, medical aesthetics, and maternity centers. It has developed a full industry chain layout that includes medical services, medical device R&D, production and sales, pharmaceutical smart supply chain, and SPD services. The company leverages digital and intelligent technology capabilities to enhance the overall synergy of the industry chain and has been recognized as a high-tech enterprise [3].